WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2007

Mar 1, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2007-02-27

Reporting Person: HARGESHEIMER ROBERT S (President - The Tech Group)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2007-02-27	Common Stock	A	477.28	$44.7700	Acquired	19700.9709	Direct
2007-02-27	Common Stock	A	5049	$44.9700	Acquired	24749.9709	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2007-02-27	Stock Option (Right to Buy)	$44.9700	A	13169	Acquired	2018-02-27	Common Stock (13169.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4554.9879	Indirect

Footnotes

F1: Bonus and incentive shares granted on 2/27/07.

F2: Shares represent the portion of the Performance Vesting Restricted Share Awards granted in 2004 that have vested for performance period III.

F3: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.